Literature DB >> 7719956

Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise.

H Roos1, L Dahlberg, L A Hoerrner, M W Lark, E J Thonar, M Shinmei, U Lindqvist, L S Lohmander.   

Abstract

The concentrations of cartilage proteoglycan (aggrecan), stromelysin-1, tissue inhibitor of metalloproteinases-1 (TIMP-1) and procollagen II C-propeptide in knee joint fluid and the levels of aggrecan, hyaluronan and keratan sulfate in serum were measured before and after exercise in 33 healthy athletes. The samples before exercise were obtained after 24 h rest from running or soccer and the samples after exercise were obtained 30-60 min after the exercise. Nine athletes ran on a treadmill for 60 min, 16 ran on road for 80 min and 8 played one soccer game (90 min). A reference group of 28 patients with knee pain but not evidence of joint pathology or injury was used for comparison. In joint fluid no single marker from the degradative processes in cartilage matrix changed significantly with exercise but all showed a rising trend. All markers except stromelysin showed lower concentrations in athletes at rest compared to the reference group. In serum from runners before exercise the concentration of keratan sulfate was significantly higher than in both the soccer and reference groups and further increased after exercise. The increase in markers after exercise may reflect an effect of mechanical loading in combination with a possible high turnover rate of body cartilage matrix in these individuals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719956     DOI: 10.1016/s1063-4584(05)80033-0

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  19 in total

1.  Cartilage metabolism--a response.

Authors:  S L Myers; K D Brandt
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

2.  Exercise-driven metabolic pathways in healthy cartilage.

Authors:  A D Blazek; J Nam; R Gupta; M Pradhan; P Perera; N L Weisleder; T E Hewett; A M Chaudhari; B S Lee; B Leblebicioglu; T A Butterfield; S Agarwal
Journal:  Osteoarthritis Cartilage       Date:  2016-02-27       Impact factor: 6.576

3.  MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.

Authors:  I Tchetverikov; L S Lohmander; N Verzijl; T W J Huizinga; J M TeKoppele; R Hanemaaijer; J DeGroot
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

4.  Increased concentrations of bone sialoprotein in joint fluid after knee injury.

Authors:  L S Lohmander; T Saxne; D Heinegård
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

5.  Synovial fluid chondroitin sulphate epitopes 3B3 and 7D4, and glycosaminoglycan in human knee osteoarthritis after exercise.

Authors:  J C Bautch; M K Clayton; Q Chu; K A Johnson
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  The Trabecular Meshwork: A Basic Review of Form and Function.

Authors:  Diala W Abu-Hassan; Ted S Acott; Mary J Kelley
Journal:  J Ocul Biol       Date:  2014-05

7.  Moderate loading of the human osteoarthritic knee joint leads to lowering of intraarticular cartilage oligomeric matrix protein.

Authors:  Ida C Helmark; Marie C H Petersen; Helle E Christensen; Michael Kjaer; Henning Langberg
Journal:  Rheumatol Int       Date:  2011-01-19       Impact factor: 2.631

8.  A time-course evaluation of inflammatory and oxidative markers following high-intensity exercise in horses: a pilot study.

Authors:  Jennifer L MacNicol; Michael I Lindinger; Wendy Pearson
Journal:  J Appl Physiol (1985)       Date:  2017-10-26

9.  Modification of plasma glycosaminoglycans in long distance runners.

Authors:  M Contini; S Pacini; L Ibba-Manneschi; V Boddi; M Ruggiero; G Liguri; M Gulisano; C Catini
Journal:  Br J Sports Med       Date:  2004-04       Impact factor: 13.800

10.  Synoviocytes protect cartilage from the effects of injury in vitro.

Authors:  Christina M Lee; John D Kisiday; C Wayne McIlwraith; Alan J Grodzinsky; David D Frisbie
Journal:  BMC Musculoskelet Disord       Date:  2013-02-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.